Nathalie K. Zgheib
Cited by
Cited by
Liver disease selectively modulates cytochrome P450–mediated metabolism
RF Frye, NK Zgheib, GR Matzke, D Chaves‐Gnecco, M Rabinovitz, ...
Clinical Pharmacology & Therapeutics 80 (3), 235-245, 2006
Using team-based learning to teach pharmacology to second year medical students improves student performance
NK Zgheib, JA Simaan, R Sabra
Medical teacher 32 (2), 130-135, 2010
Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer
P Saladores, T Mürdter, D Eccles, B Chowbay, NK Zgheib, S Winter, ...
The pharmacogenomics journal 15 (1), 84-94, 2015
Clinical outcomes of intravenous immune globulin in severe Clostridium difficile-associated diarrhea
P Juang, SJ Skledar, NK Zgheib, DL Paterson, EN Vergis, WD Shannon, ...
American journal of infection control 35 (2), 131-137, 2007
Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia
NK Zgheib, M Akra-Ismail, C Aridi, R Mahfouz, MR Abboud, H Solh, ...
Pharmacogenetics and genomics 24 (8), 387-396, 2014
Using team‐based learning to teach clinical pharmacology in medical school: student satisfaction and improved performance
NK Zgheib, JA Simaan, R Sabra
The Journal of Clinical Pharmacology 51 (7), 1101-1111, 2011
Short telomere length is associated with aging, central obesity, poor sleep and hypertension in Lebanese individuals
NK Zgheib, F Sleiman, L Nasreddine, M Nasrallah, N Nakhoul, H Isma’eel, ...
Aging and disease 9 (1), 77, 2018
Validation of incorporating flurbiprofen into the Pittsburgh cocktail
NK Zgheib, RF Frye, TS Tracy, M Romkes, RA Branch
Clinical Pharmacology & Therapeutics 80 (3), 257-263, 2006
Validation of incorporating flurbiprofen into the Pittsburgh cocktail
NK Zgheib, RF Frye, TS Tracy, M Romkes, RA Branch
Clinical Pharmacology & Therapeutics 80 (3), 257-263, 2006
BRCA1 and BRCA2 Mutations in Ethnic Lebanese Arab Women With High Hereditary Risk Breast Cancer
NS El Saghir, NK Zgheib, HA Assi, KE Khoury, Y Bidet, SM Jaber, ...
The oncologist 20 (4), 357-364, 2015
The long-term impact of team-based learning on medical students’ team performance scores and on their peer evaluation scores
NK Zgheib, Z Dimassi, I Bou Akl, KF Badr, R Sabra
Medical teacher 38 (10), 1017-1024, 2016
Improved prediction of endoxifen metabolism by CYP2D6 genotype in breast cancer patients treated with tamoxifen
W Schroth, S Winter, T Mürdter, E Schaeffeler, D Eccles, B Eccles, ...
Frontiers in pharmacology 8, 582, 2017
Bisphenol A urinary level, its correlates, and association with cardiometabolic risks in Lebanese urban adults
Y Mouneimne, M Nasrallah, N Khoueiry-Zgheib, L Nasreddine, ...
Environmental monitoring and assessment 189, 1-13, 2017
NUDT15 and TPMT genetic polymorphisms are related to 6‐mercaptopurine intolerance in children treated for acute lymphoblastic leukemia at the Children's Cancer Center of Lebanon
NK Zgheib, R Akika, R Mahfouz, CA Aridi, KM Ghanem, R Saab, ...
Pediatric blood & cancer 64 (1), 146-150, 2017
Influence of CYP2C9 and VKORC1 Polymorphisms on Warfarin and Acenocoumarol in a Sample of Lebanese People
MO Esmerian, Z Mitri, MZ Habbal, E Geryess, G Zaatari, S Alam, ...
The Journal of Clinical Pharmacology 51 (10), 1418-1428, 2011
miRNA as potential biomarkers of breast cancer in the Lebanese population and in young women: a pilot study
FJ Nassar, M El Sabban, NK Zgheib, A Tfayli, F Boulos, M Jabbour, ...
PloS one 9 (9), e107566, 2014
Crowd-funded micro-grants for genomics and “big data”: an actionable idea connecting small (artisan) science, infrastructure science, and citizen philanthropy
V Özdemir, KF Badr, ES Dove, L Endrenyi, CJ Geraci, PJ Hotez, D Milius, ...
Omics: a journal of integrative biology 17 (4), 161-172, 2013
A signature of four circulating microRNAs as potential biomarkers for diagnosing early-stage breast cancer
MM Itani, FJ Nassar, AH Tfayli, RS Talhouk, GK Chamandi, ARS Itani, ...
International journal of molecular sciences 22 (11), 6121, 2021
Implementation and obstacles of pharmacogenetics in clinical practice: an international survey
E Abou Diwan, RI Zeitoun, L Abou Haidar, I Cascorbi, N Khoueiry Zgheib
British Journal of Clinical Pharmacology 85 (9), 2076-2088, 2019
Designing a strategy to promote safe, innovative off-label use of medications
N Ansani, C Sirio, T Smitherman, B Fedutes-Henderson, S Skledar, ...
American Journal of Medical Quality 21 (4), 255-261, 2006
The system can't perform the operation now. Try again later.
Articles 1–20